Malignant solid tumour, HIV infection and tuberculosis in children: an unholy triad

被引:12
作者
Hadley, G. P. [1 ]
Naude, F. [2 ]
机构
[1] Univ KwaZulu Natal, Dept Paediat Surg, Durban, South Africa
[2] Inkosi Albert Luthuli Hosp, Dept Nucl Med, Durban, South Africa
关键词
Solid tumours; HIV infection; Tuberculosis; FDG-PET scanning; LUNG-CANCER; AFRICA; HEALTH;
D O I
10.1007/s00383-009-2409-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Co-morbidities introduce confounding variables into investigational protocols and complicate both diagnosis and management of children with malignant solid tumours. Such patients who are coincidentally HIV infected and who also have pulmonary or abdominal tuberculosis pose a particular challenge. The purpose of this report is to describe the diagnostic and management difficulties encountered in a small cadre of 18 HIV-infected children with solid tumours presenting to the Department of Paediatric Surgery. A retrospective descriptive study of HIV-infected children with malignant solid tumours. 18 HIV-infected children were identified with a variety of primary tumours. 11 children had confirmed pulmonary or abdominal tuberculosis and in 4 the diagnosis was suspected. Neoadjuvant chemotherapy was used when possible to provide a window of opportunity to investigate co-morbidity and improve health status, inter alia, improving the patients' nutritional status. FDG-PET scanning proved unreliable in discriminating between malignant and inflammatory pathology. Overall survival was 33%. The coincidence of malignancy, HIV infection and tuberculosis carries a high mortality independent of the primary tumour type.
引用
收藏
页码:697 / 701
页数:5
相关论文
共 17 条
[1]  
Abdallah F K, 2001, East Afr Med J, V78, pS43
[2]  
[Anonymous], AIDS
[3]   Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century [J].
De Cock, KM ;
Mbori-Ngacha, D ;
Marum, E .
LANCET, 2002, 360 (9326) :67-72
[4]   Immune reconstitution inflammatory syndrome in HIV-Infected patients receiving Antiretroviral therapy - Pathogenesis, clinical manifestations and management [J].
Dhasmana, Devesh J. ;
Dheda, Keertan ;
Ravn, Pernille ;
Wilkinson, Robert J. ;
Meintjes, Graeme .
DRUGS, 2008, 68 (02) :191-208
[5]   Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies [J].
Friedland, Gerald ;
Harries, Anthony ;
Coetzee, David .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 :S114-S123
[6]   Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa [J].
Gandhi, Neel R. ;
Moll, Anthony ;
Sturm, A. Willem ;
Pawinski, Robert ;
Govender, Thiloshini ;
Lalloo, Umesh ;
Zeller, Kimberly ;
Andrews, Jason ;
Friedland, Gerald .
LANCET, 2006, 368 (9547) :1575-1580
[7]  
HADLEY GP, 1990, S AFR MED J, V77, P565
[8]   Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis -: A postitron emission tomography study [J].
Hara, T ;
Kosaka, N ;
Suzuki, T ;
Kudo, K ;
Niino, H .
CHEST, 2003, 124 (03) :893-901
[9]   18F-FDG PET for mediastinal staging of lung cancer:: Which SUV threshold makes sense? [J].
Hellwig, Dirk ;
Graeter, Thomas P. ;
Ukena, Dieter ;
Groeschel, Andreas ;
Sybrecht, Gerhard W. ;
Schaefers, Hans-Joachim ;
Kirsch, Carl-Martin .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (11) :1761-1766
[10]  
KEOU FXM, 1992, E AFR MED J, V69, P550